Skip to main content
Jason Shohet, MD, Pediatric Hematology & Oncology, Worcester, MA

JasonShohetMDPh.D.

Pediatric Hematology & Oncology Worcester, MA

Associate Professor, Pediatric Oncology, Baylor College of Medicine

Dr. Shohet is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shohet's full profile

Already have an account?

  • Office

    55 Lake Ave N
    Worcester, MA 01655
    Phone+1 774-441-8083
    Fax+1 774-441-8057

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 1996 - 1999
  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1995 - 1996
  • Baylor College of Medicine (Houston)
    Baylor College of Medicine (Houston)Residency, Pediatrics, 1993 - 1995
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1993

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1999 - 2026
  • ME State Medical License
    ME State Medical License 2023 - 2025
  • TX State Medical License
    TX State Medical License 2000 - 2025
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Other

Press Mentions

  • An ALYREF-MYCN Coactivator Complex Drives Neuroblastoma Tumorigenesis Through Effects on USP3 and MYCN Stability
    An ALYREF-MYCN Coactivator Complex Drives Neuroblastoma Tumorigenesis Through Effects on USP3 and MYCN StabilityMarch 25th, 2021
  • A Novel Combination Therapy Targeting Ubiquitin-Specific Protease 5 in MYCN-Driven Neuroblastoma
    A Novel Combination Therapy Targeting Ubiquitin-Specific Protease 5 in MYCN-Driven NeuroblastomaMarch 3rd, 2021